-
IntroducedFeb 20, 2025
-
Passed Senate
-
Passed House
-
Signed into Law
AN ACT CONCERNING PRESCRIPTION DRUGS, DEVICES AND NONLEGEND DRUGS. To (1) require the Commissioner of Consumer Protection to adopt regulations to (A) ensure that nonsterile compounding pharmacies are able to engage in nonsterile compounding of drug products that include levonorgestrel, mifepristone, misoprostol or a similar component as an active ingredient, and (B) provide for the Department Consumer Protection, or one or more public-private partnerships, to import levonorgestrel, mifepristone, misoprostol and similar drug products and components, (2) eliminate a provision requiring the department to prominently post on its Internet web site certain information concerning pharmaceutical representatives, and (3) authorize certain persons working under the direct supervision of veterinarians to dispense prescription veterinary drugs.
Last Action See all actions
Senate • Apr 09, 2025: File Number 608 (LCO)
Latest Bill Text See all bill texts
Senate Calendar: Senate Calendar, Apr 16, 2025
Position: 333
Summary/Bill Text
Comments on SB 1355
Tweets
Whip Lists
Sponsors
- General Law Committeeprimary
Votes
Actions
- Apr 09, 2025 | Senate
- Reported Out of Legislative Commissioners' Office (LCO)
- Favorable Report, Tabled for the Calendar, Senate
- Senate Calendar Number 333
- File Number 608 (LCO)
- Apr 03, 2025 | Senate
- Referred to Office of Legislative Research and Office of Fiscal Analysis 04/08/25 5:00 PM (LCO)
- Mar 24, 2025 | Senate
- Joint Favorable Substitute (GL)
- Filed with Legislative Commissioners' Office (LCO)
- Feb 21, 2025 | Senate
- Public Hearing 02/26
- Feb 20, 2025 | Senate
- Referred to Joint Committee on General Law